878
Participants
Start Date
August 6, 2012
Primary Completion Date
March 17, 2015
Study Completion Date
January 12, 2016
Placebo
Form=solution for injection, route=subcutaneous use; every 2 weeks from Week 0 through Week 22.
Placebo
Form=solution for injection, route=subcutaneous use; Weeks 2, 6, and every 4 weeks through Week 52.
Sirukumab
Type=exact, unit=mg, number=50 or 100, form=solution for injection, route=subcutaneous use; every 2 weeks for 100 mg and every 4 weeks for 50 mg, Week 23 through Week 52.
Sirukumab
Type=exact, unit=mg, number=100, form=solution for injection, route=subcutaneous use; Weeks 0, 2, and every 2 weeks through Week 52.
Sirukumab
Type=exact, unit=mg, number=50, form=solution for injection, route=subcutaneous use; Weeks 0, 4, and every 4 weeks through Week 52.
Birmingham
Glendale
Mesa
Phoenix
Covina
El Cajon
Hemet
Huntington Beach
La Jolla
La Palma
Placentia
Santa Monica
Tustin
Upland
Victorville
Whittier
Hamden
Aventura
Boca Raton
Brandon
Daytona Beach
Lake Mary
Miami
Naples
Orlando
Palm Harbor
Plantation
Sarasota
Tampa
Zephyrhills
Boise
Idaho Falls
Indianapolis
Cedar Rapids
Bowling Green
Monroe
Shreveport
Cumberland
Frederick
Hagerstown
Eagan
Rochester
Flowood
Tupelo
Springfield
St Louis
Omaha
Las Vegas
Freehold
Albuquerque
Brooklyn
Lake Success
Plainview
Charlotte
Hickory
Cincinnati
Columbus
Dayton
Middleburg Heights
Edmond
Tulsa
Erie
Pittsburgh
Wyomissing
East Greenwich
Charleston
Austin
Carrollton
Corpus Christi
Cypress
Dallas
Houston
Katy
Lubbock
Mesquite
Richmond
Victoria
Kennewick
Seattle
Beckley
Clarksburg
Buenos Aires
Rosario
San Miguel de Tucumán
Campbelltown
Victoria Park
Vienna
Liège
Victoria
Winnipeg
St. John's
Kitchener
Burlington
St. John's
Toronto
Zagreb
Paris
Toulouse
Berlin
Cologne
Dresden
Erfurt
Frankfurt am Main
Gÿttingen N/A
Hamburg
Herne
Kiel Kronshagen
Schwerin
Vogelsang-Gommern
Würzburg
Zerbst
Ayauta
Bunkyō City
Fukuoka
Fukuyama
Higashihiroshima
Hiroshima
Izumo
Kagoshima
Katō
Kawagoe
Kita-Gun
Kumamoto
Kurume
Matsuyama
Miyazaki
Nagano
Nagasaki
Nagoya
Nishimuro-Gun
Nishinomiya
Okayama
Osaka
Sapporo
Sasebo
Shibata
Shimonoseki
Shimotsuke
Shinjuku-Ku
Sumida-Ku
Takaoka,Toyama
Takasaki
Tokorozawa
Tokushima
Tomakomai
Tomishiro
Tonami
Tsu
Ureshino
Yokohama
Kaunas
Klaipėda
Guadalajara
Mérida
San Luis Potosí City
Sneek
Christchurch
Hamilton
Wellington
Bydgoszcz
Elblag
Lublin
Poznan
Ustroń
Warsaw
Coimbra
Lisbon
San Juan
Barnaul
Moscow
Novosibirsk
Omsk
Orenburg
Ryazan
Saint Petersburg
Saratov
Ulyanovsk
Busan
Daegu
Daejeon
Gwangju
Incheon
Jeonju
Seongnam-si
Seoul
Suwon
A Coruña
Bilbao
Madrid
Mérida
San Cristóbal de La Laguna
Santander
Santiago de Compostela
Kaohsiung City
Taichung
Taipei
Barnsley
London
Middlesbrough
Sheffield
Wigan
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Janssen Research & Development, LLC
INDUSTRY